DiaSorin, IT0003492391

DiaSorin completes EUR 250 million buyback: stock pre-market at EUR 76.25, minus 0.60 percent

Published on 10/08/2026 at 08:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DiaSorin stock was at EUR 76.25 pre-market on October 8, 2026, according to Lang & Schwarz. The shares were down 0.60 percent from the previous session.

Techniker im Reinraum bedienen automatisierte Diagnostikgeräte in modernem Biotech-Labor
Modernes Diagnostiklabor von DiaSorin S.p.A., ISIN IT0003497168, zeigt präzise Biotech-Produktion und klinische Fertigung, Illustration mit AI erstellt.

DiaSorin completed its share buyback program on October 5, 2026, after purchasing a total of 3,790,952 treasury shares for EUR 249,999,986.67, according to an Euronext Milan filing issued October 7. DiaSorin stock was at EUR 76.25 pre-market at 8:23 a.m. CEST on October 8, 2026, down 0.60 percent versus the prior close of EUR 76.71 on October 7 at Lang & Schwarz.

Pre-market trading

Lang & Schwarz showed a bid of EUR 76.14 and an ask of EUR 76.36 alongside the pre-market price. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of DiaSorin stock.

Buyback completed

DiaSorin S.p.A. said the purchases were made under a program authorized by the shareholders’ meeting on January 27, 2026. The program was designed to cancel the repurchased shares without reducing share capital and had a maximum expenditure of EUR 250 million, with a limit of 4.5 million shares.

The final purchase took place on October 5, when DiaSorin bought 40,523 shares for EUR 3,072,062.95 at an average price of EUR 75.8104. The company said the program’s purchases represented 6.78 percent of share capital. Including treasury shares already held, DiaSorin had 6,683,050 treasury shares, equal to 11.95 percent of share capital, as of October 5.

More news and analysis on DiaSorin stock

Disclaimer...

en | IT0003492391 | DIASORIN | boerse | 70262463 | bgmi